ArticleBMC research notes2025
myCOtrak: an app which records smoking, nicotine use and exhaled carbon monoxide concentrations concurrently for use in smoking research.
Article in BMC research notes, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveSmoking during pregnancy poses significant health risks, necessitating accurate continuous monitoring of pregnant women's smoking behaviours. Existing methods relying on self-reporting lack objectivity, while biochemical measures like exhaled carbon monoxide (CO) provide validation but suffer from low participant engagement. We developed myCOtrak to address these limitations by integrating real-time CO monitoring with self-reported smoking, nicotine replacement therapy (NRT), and e-cigarette use.
resultsmyCOtrak combines automated CO data from the Bedfont iCO monitor with daily surveys. It demonstrated high feasibility and usability in initial testing with 23 participants, with 75% continuing data submission for ≥ 14 days. Key features include seamless CO integration, cloud-based storage, and longitudinal tracking, offering a validated, scalable tool for smoking cessation research.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.